Clinical Trial Update: A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC) [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing ASP3652 to placebo in women with bladder pain syndrome/interstitial cystitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis

Drugs mentioned

• ASP3652

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Cystitis, Interstitial, Urinary Bladder Disease | Phase 2 | Status: COMPLETED